Therapeutic compounds

US9428494B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9428494-B2
Application numberUS-51309307-A
CountryUS
Kind codeB2
Filing dateNov 2, 2007
Priority dateNov 2, 2006
Publication dateAug 30, 2016
Grant dateAug 30, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides novel compounds of formula I: that are opioid receptor ligands. The invention also provides pharmaceutical compositions comprising such compounds as well as methods for treating diseases associated with opioid receptor function by administering such compounds to a mammal in need of treatment. Compounds of the invention are useful to modulate (e.g. agonize or antagonize) opioid receptor function.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound which is a compound of formula 1 or 2: or a salt thereof. 2. A compound which is a compound of formula 9 or 10:

Assignees

Inventors

Classifications

  • Opioid-abuse · CPC title

  • Alcohol-abuse · CPC title

  • C07D407/04Primary

    directly linked by a ring-member-to-ring-member bond · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9428494B2 cover?
The invention provides novel compounds of formula I: that are opioid receptor ligands. The invention also provides pharmaceutical compositions comprising such compounds as well as methods for treating diseases associated with opioid receptor function by administering such compounds to a mammal in need of treatment. Compounds of the invention are useful to modulate (e.g. agonize or antagonize) o…
Who is the assignee on this patent?
Prisinzano Thomas, Univ Iowa Res Found
What technology area does this patent fall under?
Primary CPC classification C07D407/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).